PreciGenome
PrivateCompany Overview
PreciGenome is a life sciences company that develops microfluidic technology, PCR systems, and lipid nanoparticle synthesis solutions for pharmaceutical and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PreciGenome Comparables
Compare PreciGenome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inside Therapeutics | 84% | |
| Danaher | 81% | |
| Hangzhou TinkerBio Technology Co., Ltd. | 79% |
PreciGenome Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2024
Grew 43% QoQ, from 7 to 10 employees.
PreciGenome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PreciGenome's valuation, stock price, and market status.
Is PreciGenome a public or private company?
PreciGenome is a private company.
What is the current stock price of PreciGenome?
PreciGenome is a private company with no public stock price. No recent secondary market data is available.
How much is PreciGenome worth (valuation)?
Valuation information for PreciGenome is not publicly available.
Can I buy PreciGenome stock?
PreciGenome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PreciGenome's last funding round?
Funding round information for PreciGenome is not publicly available.
Who are the main investors in PreciGenome?
Investor information for PreciGenome is not publicly disclosed.
Will PreciGenome IPO soon?
No public IPO plans have been announced for PreciGenome.
How can I track PreciGenome secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PreciGenome's secondary market activity and sign up for updates.